Blepharospasm: Clinical Trials

4 trials for Blepharospasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Terminated 1

Follow Blepharospasm: new trials by email Literature Review of Blepharospasm trials Research Report on Blepharospasm

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Topical Botulinum Toxin Eyedrop on Palpebral Fissure
Botulinum toxin - Tears; Excess, Eyelid Spasm
Phase 4TerminatedUniversity of Miami22022-11-292024-12-05
Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm
Botulinum Toxin Type A 100Unit/Vial (Product), Saline Solution for Injection - Blepharospasm, Hemifacial Spasm
Phase 4CompletedThe University of Hong Kong1002015-07-012019-04-26
Efficacy of Aurosling in Frontalis Sling Suspension Surgery
Aurosling - Ptosis, Eyelid
Phase 4CompletedAurolab162009-01-012012-07-12
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm
Botulinum Toxin Type A 900kDa, Botulinum Toxin Type A 150kDa - Blepharospasm
Phase 4CompletedAllergan652006-07-012013-11-19

Narrower conditions

Blepharoptosis (1)  ·  Dystonia (1)  ·  Hemifacial Spasm (1)  ·  Lacerations (1)  ·  Ophthalmoplegia (1)

Broader conditions

Eye Diseases (4)  ·  Eyelid Diseases (4)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Cranial Nerve Diseases (1)  ·  Dyskinesias (1)  ·  Mouth Diseases (1)  ·  Neuromuscular Manifestations (1)  ·  Ocular Motility Disorders (1)  ·  Paralysis (1)  ·  Spasm (1)  ·  Stomatognathic Diseases (1)  ·  Wounds and Injuries (1)

Interventions

Botulinum Toxins, Type A (3)  ·  Botulinum Toxins (1)  ·  Injections (1)  ·  Pharmaceutical Preparations (1)  ·  Saline Solution (1)  ·  incobotulinumtoxinA (1)

Sponsors

Allergan (1)  ·  Aurolab (1)  ·  The University of Hong Kong (1)  ·  University of Miami (1)

Countries

Germany (1)  ·  India (1)  ·  United States (1)

Top investigators

Marcus M Marcet, MD (1)  ·  Usha Kim, DO, Dip NB (1)  ·  Wendy Lee, MD (1)